PMID: 6110195Feb 1, 1981Paper

Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?

Neurology
V W Henderson, G F Wooten

Abstract

The neuroleptic malignant syndrome (NMS) of extrapyramidal signs and hyperthermia is an uncommon complication of therapy with the major tranquilizers. Other manifestations are pallor, diaphoresis, blood pressure fluctuation, tachycardia, and tachypneic hypoventilation, which may necessitate respirator support. Death often occurs, but full recovery can result with prompt recognition and proper management. In a patient with Parkinson disease and a chronic psychiatric disorder treated with haloperidol, typical features of NMS appeared upon cessation of dopaminergic antiparkinsonian drugs. Manifestations of NMS are attributed to dopamine receptor blockade in the striatum, increasing thermogenesis, and in the hypothalamus, impairing heat dissipation.

Citations

Jan 1, 1990·Movement Disorders : Official Journal of the Movement Disorder Society·M E RodriguezJ A Obeso
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·C S Lu, S J Ryu
Jan 1, 1993·Journal of Neural Transmission. General Section·J Kornhuber, M Weller
Jan 1, 1992·Journal of Neural Transmission. General Section·T BrannanM D Yahr
Jan 1, 1991·The Psychiatric Quarterly·M J Akpaffiong, P Ruiz
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·J KornhuberP Riederer
Feb 1, 1989·Italian Journal of Neurological Sciences·L Figà-Talamanca, C Gualandi
Jun 1, 1987·Italian Journal of Neurological Sciences·R SandykC R Bamford
Sep 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·D Kelly, S J Brull
Dec 17, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Edward M MillsJon E Sprague
Mar 1, 1985·Biological Psychiatry·G L Fricchione
Aug 1, 1987·Biological Psychiatry·G AddonizioS D Roth
Apr 1, 1989·Biological Psychiatry·H HermeshJ Eviatar
Feb 1, 1990·Biological Psychiatry·K Nisijima, T Ishiguro
Jul 1, 1990·Biological Psychiatry·P E KeckS L McElroy
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·T F LeeR D Myers
Jan 1, 1984·Pharmacology & Therapeutics·W G Clark, J M Lipton
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·J de LeonI de la Serna
Sep 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Sachdev
Jul 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·S S GratzG M Simpson
Dec 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·M Amore, N Zazzeri
Apr 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·G SechiG Rosati
Jan 1, 1990·General Pharmacology·M EbadiL C Murrin
Jan 1, 1991·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A DonnetA Alif Cherif
Dec 1, 1995·Journal of Clinical Anesthesia·C C Young, B S Kaufman
May 1, 1989·Disease-a-month : DM·J P Knochel
Aug 1, 1985·Psychosomatics·P S Mueller
Mar 10, 1984·Lancet
Mar 1, 1984·La Revue du praticien·F HilpertP Auzépy
Oct 21, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·G SechiG Rosati
Nov 1, 1996·The Journal of Emergency Medicine·G R Pesola, C Quinto
Oct 23, 1997·Critical Care Clinics·T C ChanR F Clark
Oct 8, 2004·Schizophrenia Research·Terence W H Chong, David J Castle
May 9, 2003·Parkinsonism & Related Disorders·Takao HashimotoNobuo Yanagisawa
May 9, 2003·Parkinsonism & Related Disorders·Hideki TakuboYoshikuni Mizuno
May 9, 2003·Parkinsonism & Related Disorders·Hideki TakuboHirotaro Narabayashi
May 9, 2003·Parkinsonism & Related Disorders·Toshihide HaradaShigenobu Nakamura
May 9, 2003·Parkinsonism & Related Disorders·Yoshikuni MizunoSadako Kuno
Mar 10, 2000·International Journal of Urology : Official Journal of the Japanese Urological Association·Y KunishimaT Tsukamoto
Jul 18, 1985·The New England Journal of Medicine·B H Guzé, L R Baxter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here